US Broker Ratings

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: High Revenue Growth Amidst Clinical Advancements

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) has recently captured the attention of investors within the healthcare sector, particularly in biotechnology, due to its staggering 2,336.30% revenue growth...

ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: Promising Pipeline and Potential Upside

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, is capturing investor interest with its robust pipeline and promising revenue growth metrics. As..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: A 31% Potential Upside in the Biotechnology Sector

For investors with a keen interest in the biotechnology sector, PTC Therapeutics, Inc. (NASDAQ: PTCT) presents a compelling opportunity with a significant potential upside. With a..

Sotera Health Company (SHC) Stock Analysis: Key Insights on Its 19.78% Potential Upside

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector, not only for its robust market cap of $5.41 billion but also for its promising..

Ultragenyx Pharmaceutical Inc. (RARE) Investor Outlook: Nearly 100% Upside Potential According to Analyst Ratings

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands out in the biotechnology sector with its distinctive focus on rare and ultra-rare genetic diseases. The company’s innovative approach and..

Perrigo Company plc (PRGO) Stock Analysis: Evaluating the 30.54% Upside Potential

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, offers a wide range of over-the-counter health and wellness solutions across the Americas and..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Assessing Growth Potential with a 57.94% Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands as a significant player in the biotechnology sector, a space known for its innovative strides in healthcare solutions. With a..

Elanco Animal Health (ELAN) Investor Outlook: Assessing a 41% Potential Upside Amid Strong Buy Ratings

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is making waves with..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A Strong Buy with 12% Upside Potential

Merit Medical Systems, Inc. (MMSI), a prominent player in the healthcare sector, is capturing investor attention with its robust growth trajectory and promising analyst ratings. Specializing..

Prestige Consumer Healthcare (PBH): Analyst Ratings and Growth Potential Offer 23% Upside for Investors

Prestige Consumer Healthcare Inc. (PBH), a key player in the healthcare sector, operates in the specialty and generic drug manufacturing industry. Headquartered in Tarrytown, New York,..

Globus Medical, Inc. (GMED) Stock Analysis: A Strong Buy with 25% Upside Potential

Globus Medical, Inc. (NYSE: GMED), a key player in the medical devices sector, is catching the eye of investors with its promising growth prospects and robust..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring a Potential 102.59% Upside in the Booming RNA Therapeutics Market

Atrium Therapeutics, Inc. (NASDAQ: RNA), a burgeoning player in the biotechnology sector, is capturing investor attention with its innovative approach to RNA therapeutics targeting cardiomyopathies. With..

Guardant Health, Inc. (GH) Stock Analysis: Assessing Growth Potential with a 15.32% Upside

Guardant Health, Inc. (GH), a leader in precision oncology, is garnering attention from investors with a robust growth trajectory and an enticing potential upside of 15.32%..

BrightSpring Health Services (BTSG): Analyst Ratings Suggest a 26% Upside Potential for this Healthcare Powerhouse

BrightSpring Health Services, Inc. (BTSG), a prominent player in the healthcare sector, is attracting significant investor attention, thanks to its robust growth trajectory and bullish analyst..

Cytokinetics, Incorporated (CYTK) Stock Analysis: 41.81% Potential Upside and Strong Buy Ratings

Investors seeking opportunities in the biotechnology sector might find Cytokinetics, Incorporated (NASDAQ: CYTK) an intriguing prospect. This South San Francisco-based biopharmaceutical company is dedicated to pioneering..

TransMedics Group, Inc. (TMDX) Stock Analysis: Healthcare Innovations with a 15.99% Upside Potential

TransMedics Group, Inc. (TMDX) is at the forefront of revolutionizing the organ transplant industry, with a focus on enhancing the viability and success rates of organ..

Baxter International Inc. (BAX) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential and Price Dynamics

Investors eyeing the healthcare sector should pay close attention to Baxter International Inc. (NYSE: BAX), a well-established player in the medical instruments and supplies industry. With..

Vaxcyte, Inc. (PCVX) Stock Analysis: Potential 87.70% Upside with Innovative Vaccine Pipeline

Vaxcyte, Inc. (PCVX), a prominent player in the biotechnology sector, is gaining significant attention from investors, driven by its robust vaccine innovation pipeline and promising market..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech with Strong Revenue Growth and Substantial Upside Potential

In the dynamic world of biotechnology, TG Therapeutics, Inc. (NASDAQ: TGTX) stands out with its robust pipeline and impressive growth metrics. With a market capitalization of..

Waters Corporation (WAT) Stock Analysis: A Strong Buy with a 7% Upside Potential

Waters Corporation (NYSE: WAT), a leader in the diagnostics and research industry within the healthcare sector, presents a compelling investment opportunity for individual investors. With its..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds